These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33173381)

  • 1. The implications of COVID-19 in radiation oncology in the United States.
    Odei B; Quick A
    Curr Oncol; 2020 Oct; 27(5):279-280. PubMed ID: 33173381
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiotherapy in the era of COVID-19.
    Lancia A; Bonzano E; Bottero M; Camici M; Catellani F; Ingrosso G
    Expert Rev Anticancer Ther; 2020 Aug; 20(8):625-627. PubMed ID: 32552073
    [No Abstract]   [Full Text] [Related]  

  • 3. Oncology care in a lower middle-income country during the COVID-19 pandemic.
    Trehan A; Jain R; Bansal D
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28438. PubMed ID: 32542968
    [No Abstract]   [Full Text] [Related]  

  • 4. Community-based Cancer Care Quality and Expertise in a COVID-19 Era and Beyond.
    Garg AK
    Am J Clin Oncol; 2020 Aug; 43(8):537-538. PubMed ID: 32520792
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of Surface Contamination With SARS-CoV-2 in a Radiation Oncology Clinic.
    Jan I; Chen K; Sayan M; Uprety P; Laumbach RJ; Ennis RD; Haffty BG
    JAMA Oncol; 2020 Oct; 6(10):1632-1634. PubMed ID: 32852509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Guideline Modifications as CMS Announces "Opening Up America Again": Comments from the Society of Surgical Oncology.
    Howe JR; Bartlett DL; Tyler DS; Wong SL; Hunt KK; DeMatteo RP;
    Ann Surg Oncol; 2020 Jul; 27(7):2111-2113. PubMed ID: 32378088
    [No Abstract]   [Full Text] [Related]  

  • 7. Canadian perspective on managing multiple myeloma during the COVID-19 pandemic: lessons learned and future considerations.
    Foley R; Kaedbey R; Song K; Venner CP; White D; Doucette S; Christofides A; Reece DE
    Curr Oncol; 2020 Oct; 27(5):270-274. PubMed ID: 33173379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Musculoskeletal oncology: patient triage and management during the COVID-19 pandemic.
    Olshinka N; Mottard S
    Curr Oncol; 2020 Oct; 27(5):e512-e515. PubMed ID: 33173391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avoiding collateral mortality in a pandemic - time to change our mindset in surgical oncology.
    Tan KK; Moran BJ; Solomon MJ
    Nat Rev Clin Oncol; 2020 Jul; 17(7):383-385. PubMed ID: 32372035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Neovascular Age-Related Macular Degeneration during the COVID-19 Pandemic.
    Corradetti G; Corvi F; Nguyen TV; Sadda SR
    Ophthalmol Retina; 2020 Aug; 4(8):757-759. PubMed ID: 32480013
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.
    Papadavid E; Scarisbrick J; Ortiz Romero P; Guaglino P; Vermeer M; Knobler R; Stadler R; Bagot M
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1633-1636. PubMed ID: 32416629
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer Management During the COVID-19 Pandemic in the United States: Results From a National Physician Cross-sectional Survey.
    Hui JYC; Yuan J; Teoh D; Thomaier L; Jewett P; Beckwith H; Parsons H; Lou E; Blaes AH; Vogel RI
    Am J Clin Oncol; 2020 Oct; 43(10):679-684. PubMed ID: 32852291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HOLA COVID-19 Study: An International Effort to Determine How COVID-19 Has Impacted Oncology Practices in Latin America.
    Bernabe-Ramirez C; Velazquez AI; Olazagasti C; Bergerot CD; Bergerot PG; Soto-Perez-de-Celis E; Duma N
    Cancer Cell; 2020 Nov; 38(5):605-608. PubMed ID: 33098754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.
    Kasperkiewicz M; Schmidt E; Fairley JA; Joly P; Payne AS; Yale ML; Zillikens D; Woodley DT
    J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):e302-e303. PubMed ID: 32333823
    [No Abstract]   [Full Text] [Related]  

  • 15. Disparities in Cancer Outcomes Due to COVID-19-A Tale of 2 Cities.
    Balogun OD; Bea VJ; Phillips E
    JAMA Oncol; 2020 Oct; 6(10):1531-1532. PubMed ID: 32789508
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey.
    Breccia M; Abruzzese E; Bocchia M; Bonifacio M; Castagnetti F; Fava C; Galimberti S; Gozzini A; Gugliotta G; Iurlo A; Latagliata R; Luciano L; Pregno P; Rege-Cambrin G; Rosti G; Stagno F; Tiribelli M; Foà R; Saglio G;
    Leukemia; 2020 Aug; 34(8):2260-2261. PubMed ID: 32555369
    [No Abstract]   [Full Text] [Related]  

  • 17. Implications for Design and Analyses of Oncology Clinical Trials During the COVID-19 Pandemic.
    Moskowitz CS; Panageas KS
    JAMA Oncol; 2020 Sep; 6(9):1326-1327. PubMed ID: 32556067
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute Kidney Injury in COVID-19: Another Challenge for Nephrology.
    Rudnick MR; Hilburg R
    Am J Nephrol; 2020; 51(10):761-763. PubMed ID: 33059350
    [No Abstract]   [Full Text] [Related]  

  • 19. The Impact of the COVID-19 Pandemic on Cancer Patients.
    Al-Quteimat OM; Amer AM
    Am J Clin Oncol; 2020 Jun; 43(6):452-455. PubMed ID: 32304435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting Impacts.
    Broom A; Kenny K; Page A; Cort N; Lipp ES; Tan AC; Ashley DM; Walsh KM; Khasraw M
    Clin Cancer Res; 2020 Nov; 26(22):5809-5813. PubMed ID: 32816894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.